Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.41 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL239300 | 1.00 | MAPT (0.47) | MAPTRAB9AALDH1A1CYP2C19CYP3A4 | |
| Water SCHEMBL9435219 | 0.98 | MAPT (0.45) | MAPTRAB9AALDH1A1CYP2C19CYP3A4 | |
| SCHEMBL11212746 | 0.84 | RAB9A (0.47) | MAPTRAB9AALDH1A1CYP2C19LMNA | |
| SCHEMBL8758435 | 0.84 | KIF11 (0.49) | MAPTRAB9AALDH1A1L3MBTL1CYP2C9 | |
| SCHEMBL7717526 | 0.84 | KIF11 (0.49) | MAPTRAB9AALDH1A1L3MBTL1CYP2C9 | |
| SCHEMBL133675 | 0.84 | KIF11 (0.49) | MAPTRAB9AALDH1A1L3MBTL1CYP2C9 | |
| SCHEMBL7089012 | 0.82 | CA12 (0.47) | MAPTRAB9AALDH1A1CYP3A4ALOX12 | |
| SCHEMBL3078749 | 0.82 | CA12 (0.50) | MAPTRAB9AALDH1A1TDP1POLB | |
| SCHEMBL7028109 | 0.82 | CA12 (0.47) | MAPTRAB9AALDH1A1CYP3A4ALOX12 | |
| SCHEMBL16057214 | 0.82 | CA12 (0.47) | MAPTRAB9AALDH1A1CYP3A4ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| EP-4448544-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2024-10-23 | — | — | EP | claimed |
| WO-2023111350-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-06-22 | — | — | WO | claimed |
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-10-16 | — | — | US | claimed |
| US-20110178151-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW (IL) | 2011-07-21 | — | — | US | claimed |
| EP-2262763-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2010-12-22 | — | — | EP | claimed |
| WO-2009109973-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2009-09-11 | — | — | WO | claimed |
| US-7176185-B2 | Short peptide carrier system for cellular delivery of agent | TSRL, INC. (US) | 2007-02-13 | — | — | US | claimed |
| US-20050208140-A1 | Short peptide carrier system for cellular delivery of agent | TSRL, INC. | 2005-09-22 | — | — | US | claimed |
| EP-0594540-B1 | Antiretroviral acyl compounds | CIBA GEIGY AG (CH) | 1998-04-01 | — | — | EP | claimed |
| EP-0142387-A1 | Process for the preparation of vaccines specific for LH and HCG and process for their detection | ANDA BIOLOGICALS (FR) | 1985-05-22 | — | — | EP | claimed |
| JP-60173465-A | — | — | None | — | — | JP | disclosed |
| EP-4743578-A2 | THERAPY FOR ALPHA-1 ANTITRYPSIN DEFICIENCY | Precigen, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | disclosed |
| WO-2025014986-A2 | THERAPY FOR ALPHA-1 ANTITRYPSIN DEFICIENCY | PRECIGEN, INC. (US) | 2025-01-16 | — | — | WO | disclosed |
| WO-1994008014-A1 | POLYPEPTIDES INVOLVED IN STREPTOGRAMIN BIOSYNTHESIS, NUCLEOTIDE SEQUENCES CODING FOR SAID POLYPEPTIDES AND USE THEREOF | RHONE-POULENC RORER S.A. (FR) | 1994-04-14 | — | — | WO | disclosed |
| CN-1068333-A | Has hydrazine analog derivative of pharmacologically active and preparation method thereof | CIBA GEIGY AG (CH) | 1993-01-27 | — | — | CN | disclosed |
| WO-1992010509-A1 | RENIN-INHIBITING PEPTIDES OF THE CYCLOHEXYLSTATIN TYPE, PROCESS FOR PRODUCING THE SAME AND THEIR USE IN MEDICAMENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1992-06-25 | — | — | WO | disclosed |
| JP-S60173465-A | NOVEL ADSORBENT FOR AFFINITY CHROMATOGRAPHY | WAKO PURE CHEM IND LTD | 1985-09-06 | — | — | JP | disclosed |
| EP-0142387-A1 | Process for the preparation of vaccines specific for LH and HCG and process for their detection | ANDA BIOLOGICALS (FR) | 1985-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208140-A1 | Short peptide carrier system for cellular delivery of agent | SLC43A1, DNPEP, LNPEP | MAPT 2600/4885RAB9A 2442/4885ALDH1A1 4602/4885 |
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | FABP4, LIPC, GPR119 | MAPT 1065/4885RAB9A 2307/4885ALDH1A1 939/4885 |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | CA9, CA13, CA4 | MAPT 2838/4885RAB9A 647/4885ALDH1A1 4281/4885 |
| US-20110178151-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | GPR119, FABP4, LIPC | MAPT 1149/4885RAB9A 2272/4885ALDH1A1 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.